|
11. |
Drug Therapy and Heart Failure Prevention |
|
Circulation: Journal of the American Heart Association,
Volume 107,
Issue 9,
2003,
Page 1234-1236
Jennifer Linseman,
Michael Bristow,
Preview
|
PDF (24KB)
|
|
ISSN:0009-7322
出版商:OVID
年代:2003
数据来源: OVID
|
12. |
Allograft Arteriosclerosis and Immune-Driven Angiogenesis |
|
Circulation: Journal of the American Heart Association,
Volume 107,
Issue 9,
2003,
Page 1237-1239
Peter Libby,
David Zhao,
Preview
|
PDF (128KB)
|
|
ISSN:0009-7322
出版商:OVID
年代:2003
数据来源: OVID
|
13. |
Prosthetic Heart Valves and Pregnancy |
|
Circulation: Journal of the American Heart Association,
Volume 107,
Issue 9,
2003,
Page 1240-1246
Lynne Hung,
Shahbudin Rahimtoola,
Preview
|
PDF (176KB)
|
|
ISSN:0009-7322
出版商:OVID
年代:2003
数据来源: OVID
|
14. |
Bone Marrow–Derived Cardiomyocytes Are Present in Adult Human HeartA Study of Gender-Mismatched Bone Marrow Transplantation Patients |
|
Circulation: Journal of the American Heart Association,
Volume 107,
Issue 9,
2003,
Page 1247-1249
Arjun Deb,
Shaohua Wang,
Kimberly Skelding,
Dylan Miller,
David Simper,
Noel Caplice,
Preview
|
PDF (200KB)
|
|
摘要:
Background—Recent studies have identified cardiomyocytes of extracardiac origin in transplanted human hearts, but the exact origin of these myocyte progenitors is currently unknown.Methods and Results—Hearts of female subjects (n=4) who had undergone sex-mismatched bone marrow transplantation (BMT) were recovered at autopsy and analyzed for the presence of Y chromosome–positive cardiomyocytes. Four female gender-matched BMT subjects served as controls. Fluorescence in situ hybridization (FISH) for the Y chromosome was performed on paraffin-embedded sections to identify cells of bone marrow origin with concomitant immunofluorescent labeling for &agr;-sarcomeric actin to identify cardiomyocytes. A total of 160 000 cardiomyocyte nuclei were analyzed approximating 20 000 nuclei per patient. The mean percentage of Y chromosome–positive cardiomyocytes in patients with sex-mismatched BMT was 0.23±0.06%. Not a single Y chromosome–positive cardiomyocyte was identified in any of the control patients. Immunofluorescent costaining for laminin and chromosomal ploidy analysis with FISH showed no evidence of either pseudonuclei or cell fusion in any of the chimeric cardiac myocytes identified.Conclusions—These data establish for the first time human bone marrow as a source of extracardiac progenitor cells capable of de novo cardiomyocyte formation.
ISSN:0009-7322
出版商:OVID
年代:2003
数据来源: OVID
|
15. |
Randomized Study Comparing Radiofrequency Ablation With Cryoablation for the Treatment of Atrial Flutter With Emphasis on Pain Perception |
|
Circulation: Journal of the American Heart Association,
Volume 107,
Issue 9,
2003,
Page 1250-1252
Carl Timmermans,
Gregory Ayers,
Harry Crijns,
Luz-Maria Rodriguez,
Preview
|
PDF (30KB)
|
|
摘要:
Background—Radiofrequency ablation (RF) of atrial flutter (AFL) has a high procedural efficacy, a low recurrence rate, and reports of procedure-related pain. The aim of the present study was to compare RF with cryoablation (cryo) for the treatment of AFL, with emphasis on pain perception during application of energy.Methods and Results—Fourteen patients (55±11 years, 11 males) with AFL were randomized to receive ablation of the cavotricuspid isthmus (CTI) by either RF or cryo. Cryothermia was delivered with the CryoCor Cryoablation System (10F, 6-mm tip), and radiofrequency energy was delivered with the use of an 8-mm–tip catheter. Pain was evaluated according to a visual analogue scale (VAS; 0 to 100). All patients in the cryo group were successfully ablated with a mean of 18 applications (9 sites), and RF was successful in 6 of 7 patients (not significant) with 13 applications (not significant). The mean temperature was −82°C and 55°C for cryo and RF, respectively. One patient in the cryo group perceived pain, versus all 7 patients in the RF group (P<0.05). The proportion of painful applications averaged 75.3% in the RF group and 2.0% in the cryo group (P<0.05), whereas the corresponding VAS for pain was 38.3±25.3 and 0.32±0.86, respectively (P<0.05). At 6-month follow-up, there were no recurrences of atrial flutter.Conclusion—Cryo, as compared with RF, produces significantly less pain during application. Although in the present study there was no significant difference in efficacy, larger studies will be needed to definitively compare efficacy.
ISSN:0009-7322
出版商:OVID
年代:2003
数据来源: OVID
|
16. |
Antibiotic Therapy After Acute Myocardial InfarctionA Prospective Randomized Study |
|
Circulation: Journal of the American Heart Association,
Volume 107,
Issue 9,
2003,
Page 1253-1259
Ralf Zahn,
Steffen Schneider,
Birgit Frilling,
Karlheinz Seidl,
Ulrich Tebbe,
Michael Weber,
Martin Gottwik,
Ernst Altmann,
Friedrich Seidel,
Jürgen Rox,
Ulrich Höffler,
Karl-Ludwig Neuhaus,
Jochen Senges,
Preview
|
PDF (74KB)
|
|
摘要:
Background—Infection withChlamydia pneumoniaeis suspected to contribute to the pathogenesis of human atherosclerosis. We investigated whether treatment with the macrolide antibiotic roxithromycin would reduce mortality or morbidity in patients with an acute myocardial infarction.Methods and Results—Eight hundred seventy-two patients with an acute myocardial infarction (AMI) were randomly assigned to receive double-blind treatment with either 300 mg roxithromycin or placebo daily for 6 weeks. Primary end point was total mortality during 12-month follow-up. Four hundred thirty-three patients were treated with roxithromycin and 439 with placebo. With the exception of a higher proportion of patients suffering an anterior wall AMI (48.1% in the roxithromycin group versus 40.2% in the placebo group;P=0.027) and a lower prevalence of chronic obstructive pulmonary disease in the roxithromycin group (3.5% versus 6.9%,P=0.028), baseline characteristics, reperfusion therapy, and medical treatment were well balanced between the two groups. More patients in the roxithromycin group interrupted their study medication before completion of at least 4 weeks of treatment (78 of 433 [18%] versus 48 of 439 [11%];P=0.003; odds ratio, 1.8; 95% CI, 1.2 to 2.6). Follow-up at 12 months was achieved in 868 of 872 (99.5%) patients. Total mortality at 12 months was 6.5% (28 of 431) in the roxithromycin group compared with 6.0% (26 of 437) in the placebo group (odds ratio, 1.1; 95% CI, 0.6 to 1.9;P=0.739). There were also no differences in the secondary combined end points at 12 months.Conclusions—Treatment of AMI patients with roxithromycin did not reduce event rates during 12 months of follow-up. Therefore, our findings do not support the routine use of antibiotic treatment with a macrolide in patients with AMI.
ISSN:0009-7322
出版商:OVID
年代:2003
数据来源: OVID
|
17. |
Is the Association Between Parity and Coronary Heart Disease Due to Biological Effects of Pregnancy or Adverse Lifestyle Risk Factors Associated With Child-Rearing?Findings From the British Women’s Heart and Health Study and the British Regional Heart Study |
|
Circulation: Journal of the American Heart Association,
Volume 107,
Issue 9,
2003,
Page 1260-1264
Debbie Lawlor,
Jonathan Emberson,
Shah Ebrahim,
Peter Whincup,
S. Wannamethee,
Mary Walker,
George Smith,
Preview
|
PDF (63KB)
|
|
摘要:
Background—Parity is associated with coronary heart disease (CHD) risk. In the present study, we assessed the associations between number of children and CHD in both women and men.Methods and Results—A total of 4286 women and 4252 men aged 60 to 79 years from 24 British towns were studied. Number of children was positively associated with body mass index and waist-hip ratio in both sexes. In women but not in men, number of children was inversely associated with high-density lipoprotein cholesterol and was positively associated with triglycerides and diabetes. For both sexes, similar “J” shaped associations between number of children and CHD were observed, with the prevalence lowest among those with 2 children and increasing linearly with each additional child beyond 2. For those with at least 2 children, each additional child increased the age-adjusted odds of CHD by 30% (odds ratio, 1.30; 95% confidence interval, 1.17 to 1.44) for women and by 12% for men (odds ratio, 1.12; 95% confidence interval, 1.02 to 1.22). Adjustment for obesity and metabolic risk factors attenuated the associations between greater number of children and CHD in both sexes, although in women some association remained.Conclusions—Lifestyle risk factors associated with child-rearing lead to obesity and result in increased CHD in both sexes; biological responses of pregnancy may have additional adverse effects in women.
ISSN:0009-7322
出版商:OVID
年代:2003
数据来源: OVID
|
18. |
Heparin-Coated Stent Placement for the Treatment of Stenoses in Small Coronary Arteries of Symptomatic Patients |
|
Circulation: Journal of the American Heart Association,
Volume 107,
Issue 9,
2003,
Page 1265-1270
Michael Haude,
Thomas Konorza,
Uldis Kalnins,
Andrejs Erglis,
Kari Saunamäki,
Helmut Glogar,
Eberhard Grube,
Robert Gil,
Antonio Serra,
Hans Richardt,
Peter Sick,
Raimund Erbel,
Preview
|
PDF (73KB)
|
|
摘要:
Background—The role of stents, especially of heparin-coated stents for the treatment of stenoses in small coronary arteries, is still unclear. Therefore, we performed this prospective, randomized trial to evaluate the angiographic and clinical outcome after treatment of stenoses in small coronary arteries (2.0 to 2.6 mm) of symptomatic patients.Methods and Results—We randomly assigned 588 patients to angioplasty (n=195), bare stenting (n=196), or heparin-coated stenting (n=197). The primary end point was minimal lumen diameter (MLD) at 6 months. With comparable baseline parameters, the two stent arms showed a larger postinterventional MLD, larger acute gain, and smaller residual percent diameter stenosis, although a residual stenosis of 12±16% was achieved in the angioplasty arm, including a 27% crossover rate to stenting. Eighty percent of patients had follow-up angiography, which documented a borderline significantly larger MLD and smaller percent diameter stenosis for the two stent groups (1.34±0.48 mm and 42±20% after angioplasty, 1.47±0.48 mm and 36±20% after bare stenting, and 1.45±0.54 mm and 38±23% after heparin-coated stenting;P=0.049 andP=0.038, respectively), but restenosis rates were not different (32%, 25%, and 30%). Thrombotic events occurred in 1.0% after angioplasty and 0.5% after bare or heparin-coated stenting. Survival without myocardial infarction or target vessel revascularization at 250 days was 84.6% (angioplasty), 88.3% (bare stenting), and 88.3% (heparin-coated stenting; log-rankP=0.39).Conclusion—Compared with angioplasty with provisional stenting, bare and heparin-coated stenting confer superior angiographic results and a nonsignificant 24% reduction in clinical events, with no difference between bare and heparin-coated stenting in the treatment of stenoses in small coronary arteries.
ISSN:0009-7322
出版商:OVID
年代:2003
数据来源: OVID
|
19. |
Twenty-Year Survival After Coronary Artery SurgeryAn Institutional Perspective From Emory University |
|
Circulation: Journal of the American Heart Association,
Volume 107,
Issue 9,
2003,
Page 1271-1277
William Weintraub,
Stephen Clements,
L. Crisco,
Robert Guyton,
Joseph Craver,
Ellis Jones,
Charles Hatcher,
Preview
|
PDF (92KB)
|
|
摘要:
Background—Coronary artery bypass graft (CABG) surgery has been performed frequently for symptomatic coronary atherosclerotic heart disease for more than 30 years. However, uncertainty exists regarding the relationship between long-term survival after CABG and readily available clinical correlates of mortality.Methods and Results—We studied outcome at 20 years by age, sex, and other variables in 3939 patients who had CABG surgery from 1973 to 1979 in the Emory University System of Healthcare. Twenty-year survival, freedom from myocardial infarction, and freedom from repeat CABG were 35.6% (95% confidence interval [CI], 33.9% to 37.3%), 66.6% (95% CI, 64.6% to 68.6%), and 59.1% (95% CI, 56.9% to 61.5%). Multivariate correlates of late mortality were age (hazard ratio [HR], 1.46 per 10 years), female sex (HR, 1.21), hypertension (HR, 1.44), angina class (HR, 1.07 per class increase of 1), prior CABG (HR, 1.72), ejection fraction (HR, 1.07 per 10-point decrease), number of vessels diseased (HR, 1.11 per 1-vessel increase), and weight (HR, 1.04 per 10 kg). Twenty-year survival by age was 55%, 38%, 22%, and 11% for age <50, 50 to 59, 60 to 69, and >70 years at the time of initial surgery. Survival at 20 years after surgery with and without hypertension was 27% and 41%, respectively. Similarly, 20-year survival was 37% and 29% for men and women.Conclusions—Symptomatic coronary atherosclerotic heart disease requiring surgical revascularization is progressive with continuing events and mortality. Clinical correlates of mortality significantly impact survival over time and may help identify long-term benefits after CABG.
ISSN:0009-7322
出版商:OVID
年代:2003
数据来源: OVID
|
20. |
Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT) |
|
Circulation: Journal of the American Heart Association,
Volume 107,
Issue 9,
2003,
Page 1278-1283
Inder Anand,
Lloyd Fisher,
Yann-Tong Chiang,
Roberto Latini,
Serge Masson,
Aldo Maggioni,
Robert Glazer,
Gianni Tognoni,
Jay Cohn,
Preview
|
PDF (267KB)
|
|
摘要:
Background—Neurohormones are considered markers of heart failure progression. We examined whether changes in brain natriuretic peptide (BNP) and norepinephrine (NE) over time are associated with corresponding changes in mortality and morbidity in the Valsartan Heart Failure Trial.Methods and Results—Plasma BNP and NE were measured before randomization and during follow-up in ≈4300 patients in the Valsartan Heart Failure Trial. The relation between baseline BNP and NE and all-cause mortality and first morbid event (M&M) was analyzed in subgroups, with values above and below the median, and by quartiles. The change and percent change from baseline to 4 and 12 months in BNP and NE were also analyzed by quartiles for subsequent M&M. Risk ratios for M&M were calculated using a Cox proportional hazard model. Risk ratio of M&M for patients with baseline BNP or NE above the median was significantly higher than that for patients with values below the median. Baseline BNP and NE in quartiles also showed a quartile-dependent increase in M&M. BNP had a stronger association with M&M than NE. Patients with the greatest percent decrease in BNP and NE from baseline to 4 and 12 months had the lowest whereas patients with greatest percent increase in BNP and NE had the highest M&M.Conclusions—Not only are plasma BNP and NE important predictors of heart failure M&M, but changes in these neurohormones over time are associated with corresponding changes in M&M. These data further reinforce their role as significant surrogate markers in HF and underscore the importance of including their measurement in HF trials.
ISSN:0009-7322
出版商:OVID
年代:2003
数据来源: OVID
|
|